Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in GIST previously treated with imatinib
NCT00457743Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in gastrointestinal stromal tumor (GIST), sponsored by Pfizer. Started Jan 2005; status: completed.
02
Drugs
sunitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00457743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457743.